These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 9161779

  • 1. Intensive chemoradiation followed by esophagectomy for squamous cell and adenocarcinoma of the esophagus.
    Forastiere AA, Heitmiller RF, Lee DJ, Zahurak M, Abrams R, Kleinberg L, Watkins S, Yeo CJ, Lillemoe KD, Sitzmann JV, Sharfman W.
    Cancer J Sci Am; 1997; 3(3):144-52. PubMed ID: 9161779
    [Abstract] [Full Text] [Related]

  • 2. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z, Zhang Z, Jin J, Ajani JA, Swisher SG, Stevens CW, Ho L, Smythe R, Vaporciyan AA, Putnam JB, Walsh GL, Roth JA, Yao JC, Allen PK, Cox JD, Komaki R.
    Int J Radiat Oncol Biol Phys; 2004 Dec 01; 60(5):1484-93. PubMed ID: 15590179
    [Abstract] [Full Text] [Related]

  • 3. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A, Putnam J, Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R.
    Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):427-36. PubMed ID: 15380576
    [Abstract] [Full Text] [Related]

  • 4. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
    Choi N, Park SD, Lynch T, Wright C, Ancukiewicz M, Wain J, Donahue D, Mathisen D.
    Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):111-22. PubMed ID: 15337546
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Management of adenocarcinoma of the esophagus with chemoradiation alone or chemoradiation followed by esophagectomy: results of sequential nonrandomized phase II studies.
    Algan O, Coia LR, Keller SM, Engstrom PF, Weiner LM, Schultheiss TE, Hanks GE.
    Int J Radiat Oncol Biol Phys; 1995 Jun 15; 32(3):753-61. PubMed ID: 7790262
    [Abstract] [Full Text] [Related]

  • 7. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report.
    Gaspar LE, Winter K, Kocha WI, Coia LR, Herskovic A, Graham M.
    Cancer; 2000 Mar 01; 88(5):988-95. PubMed ID: 10699886
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy.
    Weiner LM, Colarusso P, Goldberg M, Dresler C, Coia LR.
    Semin Oncol; 1997 Dec 01; 24(6 Suppl 19):S19-93-S19-95. PubMed ID: 9427276
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of multimodality treatment of locoregional esophageal carcinoma by Southwest Oncology Group 9060.
    Poplin EA, Jacobson J, Herskovic A, Panella TJ, Valdivieso M, Hutchins LF, Macdonald JS.
    Cancer; 1996 Nov 01; 78(9):1851-6. PubMed ID: 8909302
    [Abstract] [Full Text] [Related]

  • 11. [Cisplatin, 5-FU and preoperative radiotherapy in esophageal epidermoid cancer. Multicenter phase II FFCD 8804 study].
    Bedenne L, Seitz JF, Milan C, Renard P, Fraisse J, Conroy T, Lacourt J, Janoray P, Faivre J.
    Gastroenterol Clin Biol; 1998 Mar 01; 22(3):273-81. PubMed ID: 9762210
    [Abstract] [Full Text] [Related]

  • 12. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone.
    Ancona E, Ruol A, Santi S, Merigliano S, Sileni VC, Koussis H, Zaninotto G, Bonavina L, Peracchia A.
    Cancer; 2001 Jun 01; 91(11):2165-74. PubMed ID: 11391598
    [Abstract] [Full Text] [Related]

  • 13. Swallowing function and weight change observed in a phase I/II study of external-beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 9207).
    Gaspar LE, Winter K, Kocha WI, Pinover WH, Herskovic, Graham M, Gunderson L.
    Cancer J; 2001 Jun 01; 7(5):388-94. PubMed ID: 11693897
    [Abstract] [Full Text] [Related]

  • 14. Influence of induction chemotherapy and class of cytotoxics on pathologic response and survival after preoperative chemoradiation in patients with carcinoma of the esophagus.
    Javeri H, Arora R, Correa AM, Hofstetter WL, Lee JH, Liao Z, McAleer MF, Maru D, Bhutani MS, Swisher SG, Izzo JG, Ajani JA.
    Cancer; 2008 Sep 15; 113(6):1302-8. PubMed ID: 18623381
    [Abstract] [Full Text] [Related]

  • 15. Chemoradiotherapy for T3 and T4 squamous cell carcinoma of the esophagus using low-dose FP and radiation: a preliminary report.
    Fujiwara Y, Kamikonya N, Inoue T, Koishi K, Yoshikawa R, Nakao K, Yagyu R, Nishiwaki M, Fujiwara M, Kojima S, Nakagawa K, Yamamura T.
    Oncol Rep; 2005 Nov 15; 14(5):1177-82. PubMed ID: 16211282
    [Abstract] [Full Text] [Related]

  • 16. Neoadjuvant therapy for esophageal cancer: standard of care or elusive myth?
    Boyle MJ, Franceschi D, Robinson DS, Livingstone AS.
    Am Surg; 2001 Oct 15; 67(10):956-65. PubMed ID: 11603553
    [Abstract] [Full Text] [Related]

  • 17. Preoperative combined modality therapy with paclitaxel, carboplatin, prolonged infusion 5-fluorouracil, and radiation therapy in localized esophageal cancer: preliminary results of a Minnie Pearl Cancer Research Network phase II trial.
    Meluch AA, Hainsworth JD, Gray JR, Thomas M, Whitworth PL, Davis JL, Greco FA.
    Cancer J Sci Am; 1999 Oct 15; 5(2):84-91. PubMed ID: 10198730
    [Abstract] [Full Text] [Related]

  • 18. [The combined radiochemotherapy of inoperable esophageal neoplasms: a feasibility study].
    Sola B, Airoldi M, Orecchia R, Rovea P, Fracchia F, Boidi Trotti A, Tessa M, Foco A, Oliaro A, Casadio C, Dei Poli M.
    Radiol Med; 1996 Apr 15; 91(4):456-9. PubMed ID: 8643859
    [Abstract] [Full Text] [Related]

  • 19. Use of concurrent chemotherapy, accelerated fractionation radiation, and surgery for patients with esophageal carcinoma.
    Adelstein DJ, Rice TW, Becker M, Larto MA, Kirby TJ, Koka A, Tefft M, Zuccaro G.
    Cancer; 1997 Sep 15; 80(6):1011-20. PubMed ID: 9305700
    [Abstract] [Full Text] [Related]

  • 20. Optimal treatment for localized esophageal cancer still uncertain.
    Lord RV.
    Am J Gastroenterol; 2000 Jan 15; 95(1):305-7. PubMed ID: 10638607
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.